Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease

@inproceedings{Hanganu2014InfluenceOD,
  title={Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease},
  author={Alexandru Hanganu and Clotilde Degroot and Oury Monchi and Christophe Bedetti and B{\'e}atriz Mejia-Constain and Anne-Louise Lafontaine and Sylvain Chouinard and Marie-Andr{\'e}e Bruneau},
  booktitle={Front. Neurol.},
  year={2014}
}
INTRODUCTION Depressive symptoms are very common in patients with Parkinson's disease (PD) and have a significant impact on the quality of life. Dopaminergic medication has been shown to have an influence on the development of depressive symptoms. MATERIALS AND METHODS The present study analyzed two groups of non-demented patients with PD, with and without depressive symptoms, and reported the correlations between antiparkinsonian medication [specifically levodopa (l-DOPA) and dopaminergic… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 93 references

Depression rating scales in Parkinson's disease: critique and recommendations.

Movement disorders : official journal of the Movement Disorder Society • 2007
View 4 Excerpts
Highly Influenced

The organization of the projection from the cerebral cortex to the striatum in the rat

AJ McGeorge, Faull RLM
September 2014 | Volume 5 | Article • 2014

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Movement disorders : official journal of the Movement Disorder Society • 2012
View 1 Excerpt